Rezolute, Inc. (RZLT)
4.87
+0.23
(+4.96%)
USD |
NASDAQ |
Oct 09, 16:00
4.86
-0.01
(-0.21%)
After-Hours: 20:00
Rezolute Market Cap : 469.50M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 469.50M |
| October 08, 2026 | 447.32M |
| October 07, 2026 | 422.26M |
| October 06, 2026 | 416.47M |
| October 05, 2026 | 417.44M |
| October 02, 2026 | 386.59M |
| October 01, 2026 | 392.37M |
| September 30, 2026 | 399.12M |
| September 29, 2026 | 394.30M |
| September 28, 2026 | 402.98M |
| September 25, 2026 | 375.98M |
| September 24, 2026 | 379.84M |
| September 23, 2026 | 385.62M |
| September 22, 2026 | 389.48M |
| September 21, 2026 | 376.95M |
| September 18, 2026 | 369.76M |
| September 17, 2026 | 380.35M |
| September 16, 2026 | 383.24M |
| September 15, 2026 | 399.61M |
| September 14, 2026 | 409.24M |
| September 11, 2026 | 406.35M |
| September 10, 2026 | 401.54M |
| September 09, 2026 | 390.95M |
| September 08, 2026 | 423.69M |
| September 04, 2026 | 441.02M |
| Date | Value |
|---|---|
| September 03, 2026 | 437.17M |
| September 02, 2026 | 439.09M |
| September 01, 2026 | 433.32M |
| August 31, 2026 | 451.61M |
| August 28, 2026 | 444.87M |
| August 27, 2026 | 479.54M |
| August 26, 2026 | 485.31M |
| August 25, 2026 | 482.42M |
| August 24, 2026 | 482.42M |
| August 21, 2026 | 490.13M |
| August 20, 2026 | 448.72M |
| August 19, 2026 | 454.50M |
| August 18, 2026 | 448.72M |
| August 17, 2026 | 450.65M |
| August 14, 2026 | 442.94M |
| August 13, 2026 | 442.94M |
| August 12, 2026 | 452.57M |
| August 11, 2026 | 444.87M |
| August 10, 2026 | 450.65M |
| August 07, 2026 | 451.61M |
| August 06, 2026 | 452.57M |
| August 05, 2026 | 450.65M |
| August 04, 2026 | 478.57M |
| August 03, 2026 | 472.80M |
| July 31, 2026 | 454.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 488.54B |
| Avalo Therapeutics, Inc. | 722.09M |
| Opus Genetics, Inc. | 384.31M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
Market Cap Related Metrics
| Price to Book Value | 4.663 |
| Price | 4.87 |
| Earnings Yield | -15.33% |